0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sedation In ICU Setting Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-38J925
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Sedation In ICU Setting Market Insights and Forecast to 2028
BUY CHAPTERS

Global Sedation In ICU Setting Market Research Report 2025

Code: QYRE-Auto-38J925
Report
September 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sedation In ICU Setting Market

The global market for Sedation In ICU Setting was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Sedation is the reduction of irritability or agitation by administration of sedative drugs, generally to facilitate a medical procedure or diagnostic procedure.
North American market for Sedation In ICU Setting is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sedation In ICU Setting is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Sedation In ICU Setting in Neonatal Intensive Care Unit is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Sedation In ICU Setting include AstraZeneca, GlaxoSmithKline, Mylan, Fresenius, Teva, B. Braun Holding, Aspen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sedation In ICU Setting, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sedation In ICU Setting.
The Sedation In ICU Setting market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sedation In ICU Setting market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sedation In ICU Setting companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Sedation In ICU Setting Market Report

Report Metric Details
Report Name Sedation In ICU Setting Market
Segment by Type
  • Propofol
  • Dexmedetomidine
  • Remifentanil
  • Others
Segment by Application
  • Neonatal Intensive Care Unit
  • Child Intensive Care Unit
  • Adult Intensive Care Unit
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca, GlaxoSmithKline, Mylan, Fresenius, Teva, B. Braun Holding, Aspen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sedation In ICU Setting company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sedation In ICU Setting Market report?

Ans: The main players in the Sedation In ICU Setting Market are AstraZeneca, GlaxoSmithKline, Mylan, Fresenius, Teva, B. Braun Holding, Aspen

What are the Application segmentation covered in the Sedation In ICU Setting Market report?

Ans: The Applications covered in the Sedation In ICU Setting Market report are Neonatal Intensive Care Unit, Child Intensive Care Unit, Adult Intensive Care Unit

What are the Type segmentation covered in the Sedation In ICU Setting Market report?

Ans: The Types covered in the Sedation In ICU Setting Market report are Propofol, Dexmedetomidine, Remifentanil, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sedation In ICU Setting Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Propofol
1.2.3 Dexmedetomidine
1.2.4 Remifentanil
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sedation In ICU Setting Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neonatal Intensive Care Unit
1.3.3 Child Intensive Care Unit
1.3.4 Adult Intensive Care Unit
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sedation In ICU Setting Market Perspective (2020-2031)
2.2 Global Sedation In ICU Setting Growth Trends by Region
2.2.1 Global Sedation In ICU Setting Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sedation In ICU Setting Historic Market Size by Region (2020-2025)
2.2.3 Sedation In ICU Setting Forecasted Market Size by Region (2026-2031)
2.3 Sedation In ICU Setting Market Dynamics
2.3.1 Sedation In ICU Setting Industry Trends
2.3.2 Sedation In ICU Setting Market Drivers
2.3.3 Sedation In ICU Setting Market Challenges
2.3.4 Sedation In ICU Setting Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sedation In ICU Setting Players by Revenue
3.1.1 Global Top Sedation In ICU Setting Players by Revenue (2020-2025)
3.1.2 Global Sedation In ICU Setting Revenue Market Share by Players (2020-2025)
3.2 Global Sedation In ICU Setting Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sedation In ICU Setting Revenue
3.4 Global Sedation In ICU Setting Market Concentration Ratio
3.4.1 Global Sedation In ICU Setting Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sedation In ICU Setting Revenue in 2024
3.5 Global Key Players of Sedation In ICU Setting Head office and Area Served
3.6 Global Key Players of Sedation In ICU Setting, Product and Application
3.7 Global Key Players of Sedation In ICU Setting, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sedation In ICU Setting Breakdown Data by Type
4.1 Global Sedation In ICU Setting Historic Market Size by Type (2020-2025)
4.2 Global Sedation In ICU Setting Forecasted Market Size by Type (2026-2031)
5 Sedation In ICU Setting Breakdown Data by Application
5.1 Global Sedation In ICU Setting Historic Market Size by Application (2020-2025)
5.2 Global Sedation In ICU Setting Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sedation In ICU Setting Market Size (2020-2031)
6.2 North America Sedation In ICU Setting Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sedation In ICU Setting Market Size by Country (2020-2025)
6.4 North America Sedation In ICU Setting Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sedation In ICU Setting Market Size (2020-2031)
7.2 Europe Sedation In ICU Setting Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sedation In ICU Setting Market Size by Country (2020-2025)
7.4 Europe Sedation In ICU Setting Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sedation In ICU Setting Market Size (2020-2031)
8.2 Asia-Pacific Sedation In ICU Setting Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sedation In ICU Setting Market Size by Region (2020-2025)
8.4 Asia-Pacific Sedation In ICU Setting Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sedation In ICU Setting Market Size (2020-2031)
9.2 Latin America Sedation In ICU Setting Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sedation In ICU Setting Market Size by Country (2020-2025)
9.4 Latin America Sedation In ICU Setting Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sedation In ICU Setting Market Size (2020-2031)
10.2 Middle East & Africa Sedation In ICU Setting Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sedation In ICU Setting Market Size by Country (2020-2025)
10.4 Middle East & Africa Sedation In ICU Setting Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Sedation In ICU Setting Introduction
11.1.4 AstraZeneca Revenue in Sedation In ICU Setting Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Sedation In ICU Setting Introduction
11.2.4 GlaxoSmithKline Revenue in Sedation In ICU Setting Business (2020-2025)
11.2.5 GlaxoSmithKline Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Sedation In ICU Setting Introduction
11.3.4 Mylan Revenue in Sedation In ICU Setting Business (2020-2025)
11.3.5 Mylan Recent Development
11.4 Fresenius
11.4.1 Fresenius Company Details
11.4.2 Fresenius Business Overview
11.4.3 Fresenius Sedation In ICU Setting Introduction
11.4.4 Fresenius Revenue in Sedation In ICU Setting Business (2020-2025)
11.4.5 Fresenius Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Sedation In ICU Setting Introduction
11.5.4 Teva Revenue in Sedation In ICU Setting Business (2020-2025)
11.5.5 Teva Recent Development
11.6 B. Braun Holding
11.6.1 B. Braun Holding Company Details
11.6.2 B. Braun Holding Business Overview
11.6.3 B. Braun Holding Sedation In ICU Setting Introduction
11.6.4 B. Braun Holding Revenue in Sedation In ICU Setting Business (2020-2025)
11.6.5 B. Braun Holding Recent Development
11.7 Aspen
11.7.1 Aspen Company Details
11.7.2 Aspen Business Overview
11.7.3 Aspen Sedation In ICU Setting Introduction
11.7.4 Aspen Revenue in Sedation In ICU Setting Business (2020-2025)
11.7.5 Aspen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Sedation In ICU Setting Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Propofol
 Table 3. Key Players of Dexmedetomidine
 Table 4. Key Players of Remifentanil
 Table 5. Key Players of Others
 Table 6. Global Sedation In ICU Setting Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Sedation In ICU Setting Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Sedation In ICU Setting Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Sedation In ICU Setting Market Share by Region (2020-2025)
 Table 10. Global Sedation In ICU Setting Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Sedation In ICU Setting Market Share by Region (2026-2031)
 Table 12. Sedation In ICU Setting Market Trends
 Table 13. Sedation In ICU Setting Market Drivers
 Table 14. Sedation In ICU Setting Market Challenges
 Table 15. Sedation In ICU Setting Market Restraints
 Table 16. Global Sedation In ICU Setting Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Sedation In ICU Setting Market Share by Players (2020-2025)
 Table 18. Global Top Sedation In ICU Setting Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sedation In ICU Setting as of 2024)
 Table 19. Ranking of Global Top Sedation In ICU Setting Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Sedation In ICU Setting Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Sedation In ICU Setting, Headquarters and Area Served
 Table 22. Global Key Players of Sedation In ICU Setting, Product and Application
 Table 23. Global Key Players of Sedation In ICU Setting, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Sedation In ICU Setting Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Sedation In ICU Setting Revenue Market Share by Type (2020-2025)
 Table 27. Global Sedation In ICU Setting Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Sedation In ICU Setting Revenue Market Share by Type (2026-2031)
 Table 29. Global Sedation In ICU Setting Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Sedation In ICU Setting Revenue Market Share by Application (2020-2025)
 Table 31. Global Sedation In ICU Setting Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Sedation In ICU Setting Revenue Market Share by Application (2026-2031)
 Table 33. North America Sedation In ICU Setting Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Sedation In ICU Setting Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Sedation In ICU Setting Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Sedation In ICU Setting Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Sedation In ICU Setting Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Sedation In ICU Setting Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Sedation In ICU Setting Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Sedation In ICU Setting Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Sedation In ICU Setting Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Sedation In ICU Setting Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Sedation In ICU Setting Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sedation In ICU Setting Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Sedation In ICU Setting Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Sedation In ICU Setting Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Sedation In ICU Setting Market Size by Country (2026-2031) & (US$ Million)
 Table 48. AstraZeneca Company Details
 Table 49. AstraZeneca Business Overview
 Table 50. AstraZeneca Sedation In ICU Setting Product
 Table 51. AstraZeneca Revenue in Sedation In ICU Setting Business (2020-2025) & (US$ Million)
 Table 52. AstraZeneca Recent Development
 Table 53. GlaxoSmithKline Company Details
 Table 54. GlaxoSmithKline Business Overview
 Table 55. GlaxoSmithKline Sedation In ICU Setting Product
 Table 56. GlaxoSmithKline Revenue in Sedation In ICU Setting Business (2020-2025) & (US$ Million)
 Table 57. GlaxoSmithKline Recent Development
 Table 58. Mylan Company Details
 Table 59. Mylan Business Overview
 Table 60. Mylan Sedation In ICU Setting Product
 Table 61. Mylan Revenue in Sedation In ICU Setting Business (2020-2025) & (US$ Million)
 Table 62. Mylan Recent Development
 Table 63. Fresenius Company Details
 Table 64. Fresenius Business Overview
 Table 65. Fresenius Sedation In ICU Setting Product
 Table 66. Fresenius Revenue in Sedation In ICU Setting Business (2020-2025) & (US$ Million)
 Table 67. Fresenius Recent Development
 Table 68. Teva Company Details
 Table 69. Teva Business Overview
 Table 70. Teva Sedation In ICU Setting Product
 Table 71. Teva Revenue in Sedation In ICU Setting Business (2020-2025) & (US$ Million)
 Table 72. Teva Recent Development
 Table 73. B. Braun Holding Company Details
 Table 74. B. Braun Holding Business Overview
 Table 75. B. Braun Holding Sedation In ICU Setting Product
 Table 76. B. Braun Holding Revenue in Sedation In ICU Setting Business (2020-2025) & (US$ Million)
 Table 77. B. Braun Holding Recent Development
 Table 78. Aspen Company Details
 Table 79. Aspen Business Overview
 Table 80. Aspen Sedation In ICU Setting Product
 Table 81. Aspen Revenue in Sedation In ICU Setting Business (2020-2025) & (US$ Million)
 Table 82. Aspen Recent Development
 Table 83. Research Programs/Design for This Report
 Table 84. Key Data Information from Secondary Sources
 Table 85. Key Data Information from Primary Sources
 Table 86. Authors List of This Report


List of Figures
 Figure 1. Sedation In ICU Setting Picture
 Figure 2. Global Sedation In ICU Setting Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sedation In ICU Setting Market Share by Type: 2024 VS 2031
 Figure 4. Propofol Features
 Figure 5. Dexmedetomidine Features
 Figure 6. Remifentanil Features
 Figure 7. Others Features
 Figure 8. Global Sedation In ICU Setting Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Sedation In ICU Setting Market Share by Application: 2024 VS 2031
 Figure 10. Neonatal Intensive Care Unit Case Studies
 Figure 11. Child Intensive Care Unit Case Studies
 Figure 12. Adult Intensive Care Unit Case Studies
 Figure 13. Sedation In ICU Setting Report Years Considered
 Figure 14. Global Sedation In ICU Setting Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Sedation In ICU Setting Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Sedation In ICU Setting Market Share by Region: 2024 VS 2031
 Figure 17. Global Sedation In ICU Setting Market Share by Players in 2024
 Figure 18. Global Top Sedation In ICU Setting Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sedation In ICU Setting as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Sedation In ICU Setting Revenue in 2024
 Figure 20. North America Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Sedation In ICU Setting Market Share by Country (2020-2031)
 Figure 22. United States Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Sedation In ICU Setting Market Share by Country (2020-2031)
 Figure 26. Germany Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Sedation In ICU Setting Market Share by Region (2020-2031)
 Figure 34. China Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Sedation In ICU Setting Market Share by Country (2020-2031)
 Figure 42. Mexico Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Sedation In ICU Setting Market Share by Country (2020-2031)
 Figure 46. Turkey Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Sedation In ICU Setting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. AstraZeneca Revenue Growth Rate in Sedation In ICU Setting Business (2020-2025)
 Figure 50. GlaxoSmithKline Revenue Growth Rate in Sedation In ICU Setting Business (2020-2025)
 Figure 51. Mylan Revenue Growth Rate in Sedation In ICU Setting Business (2020-2025)
 Figure 52. Fresenius Revenue Growth Rate in Sedation In ICU Setting Business (2020-2025)
 Figure 53. Teva Revenue Growth Rate in Sedation In ICU Setting Business (2020-2025)
 Figure 54. B. Braun Holding Revenue Growth Rate in Sedation In ICU Setting Business (2020-2025)
 Figure 55. Aspen Revenue Growth Rate in Sedation In ICU Setting Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart